Neuromuscular Blockade in the Pre- and COVID-19 ARDS Patients

Neuromuscular Blockade in the Pre- and COVID-19 ARDS Patients

Acute respiratory distress syndrome (ARDS) accounts for a quarter of mechanically ventilated patients, while during the pandemic, it overwhelmed the capacity of intensive care units (ICUs). Lung protective ventilation (low tidal volume, positive-end expiratory pressure titrated to lung mechanics and...

Full description

Bibliographic Details
Main Authors: Vasiliki Tsolaki, George E. Zakynthinos, Maria-Eirini Papadonta, Fotini Bardaka, George Fotakopoulos, Ioannis Pantazopoulos, Demosthenes Makris, Epaminondas Zakynthinos
Format: Article
Language:English
Published: MDPI AG 2022-09-01
Series:Journal of Personalized Medicine
Subjects:
neuromuscular blocking agents
muscular relaxants
ARDS
survival
lung injury
COVID-19 ARDS
Online Access:https://www.mdpi.com/2075-4426/12/9/1538

Similar Items

Similar Items